Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain

BACKGROUND: To evaluate the effects of a combined oral contraceptive containing 1.5 mg 17b-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic pain (CPP) and on the quality of life (QoL) and sexual function, by...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, Salvatore, Cianci, Antonio, Iraci Sareri, Marco, Panella, Marco, Caruso, Giuseppe, Cianci, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092804/
https://www.ncbi.nlm.nih.gov/pubmed/35538479
http://dx.doi.org/10.1186/s12905-022-01737-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092804/
https://www.ncbi.nlm.nih.gov/pubmed/35538479
http://dx.doi.org/10.1186/s12905-022-01737-7

Ejemplares similares